中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2014年
3期
284-287,338
,共5页
钱倩倩%王邦宁%胡泽平%宋兵%马东宇
錢倩倩%王邦寧%鬍澤平%宋兵%馬東宇
전천천%왕방저%호택평%송병%마동우
细胞凋亡%大鼠,近交SHR%肝细胞生长因子%抗高血压药%肌细胞,心脏
細胞凋亡%大鼠,近交SHR%肝細胞生長因子%抗高血壓藥%肌細胞,心髒
세포조망%대서,근교SHR%간세포생장인자%항고혈압약%기세포,심장
Apoptosis%Rats,Inbred SHR%Hepatocyte Growth Factor%Antihypertensive Agents%Myocytes,Cardiac
目的:观察肝细胞生长因子(HGF)联合缬沙坦对自发性高血压大鼠(SHR)心肌凋亡的影响。方法24只14周龄雄性SHR随机分为4组(n=24):阳性对照组(P组,常规饲养,无药物干预)、HGF组(H组,开胸,左心室壁五点直接注射5×109 Pfu/mL Ad5-HGF,0.1 mL,术后常规饲养4周),缬沙坦组(V组,缬沙坦灌胃30 mg·kg-1·d-1,4周),HGF 联合缬沙坦组(HV 组,开胸,左心室壁五点直接注射5×109 Pfu/mL Ad5-HGF,0.1 mL,术后缬沙坦灌胃30 mg·kg-1·d-1,4周),雄性Wistar大鼠(WKY)为健康对照(N组,n=6)。治疗前及治疗后每周测量一次尾动脉压。4周后处死大鼠,TUNEL法测心肌凋亡指数,ELASA法测心肌HGF、caspase-3浓度,免疫组织化学法及图像分析系统分析心肌Bcl-xl 水平。结果治疗4周后,HV组、V组血压较P组、H组明显下降(P<0.05);与P组相比,H组、V组、HV组心肌凋亡指数及心肌caspase-3浓度明显降低(P<0.05),心肌HGF、抗心肌凋亡蛋白Bcl-xl水平明显升高(P<0.05),且联合用药组尤为显著。结论 HGF、缬沙坦均可有效抑制SHR左心室心肌细胞凋亡,改善心室重构,且联合使用效果优于HGF、缬沙坦的单独应用。
目的:觀察肝細胞生長因子(HGF)聯閤纈沙坦對自髮性高血壓大鼠(SHR)心肌凋亡的影響。方法24隻14週齡雄性SHR隨機分為4組(n=24):暘性對照組(P組,常規飼養,無藥物榦預)、HGF組(H組,開胸,左心室壁五點直接註射5×109 Pfu/mL Ad5-HGF,0.1 mL,術後常規飼養4週),纈沙坦組(V組,纈沙坦灌胃30 mg·kg-1·d-1,4週),HGF 聯閤纈沙坦組(HV 組,開胸,左心室壁五點直接註射5×109 Pfu/mL Ad5-HGF,0.1 mL,術後纈沙坦灌胃30 mg·kg-1·d-1,4週),雄性Wistar大鼠(WKY)為健康對照(N組,n=6)。治療前及治療後每週測量一次尾動脈壓。4週後處死大鼠,TUNEL法測心肌凋亡指數,ELASA法測心肌HGF、caspase-3濃度,免疫組織化學法及圖像分析繫統分析心肌Bcl-xl 水平。結果治療4週後,HV組、V組血壓較P組、H組明顯下降(P<0.05);與P組相比,H組、V組、HV組心肌凋亡指數及心肌caspase-3濃度明顯降低(P<0.05),心肌HGF、抗心肌凋亡蛋白Bcl-xl水平明顯升高(P<0.05),且聯閤用藥組尤為顯著。結論 HGF、纈沙坦均可有效抑製SHR左心室心肌細胞凋亡,改善心室重構,且聯閤使用效果優于HGF、纈沙坦的單獨應用。
목적:관찰간세포생장인자(HGF)연합힐사탄대자발성고혈압대서(SHR)심기조망적영향。방법24지14주령웅성SHR수궤분위4조(n=24):양성대조조(P조,상규사양,무약물간예)、HGF조(H조,개흉,좌심실벽오점직접주사5×109 Pfu/mL Ad5-HGF,0.1 mL,술후상규사양4주),힐사탄조(V조,힐사탄관위30 mg·kg-1·d-1,4주),HGF 연합힐사탄조(HV 조,개흉,좌심실벽오점직접주사5×109 Pfu/mL Ad5-HGF,0.1 mL,술후힐사탄관위30 mg·kg-1·d-1,4주),웅성Wistar대서(WKY)위건강대조(N조,n=6)。치료전급치료후매주측량일차미동맥압。4주후처사대서,TUNEL법측심기조망지수,ELASA법측심기HGF、caspase-3농도,면역조직화학법급도상분석계통분석심기Bcl-xl 수평。결과치료4주후,HV조、V조혈압교P조、H조명현하강(P<0.05);여P조상비,H조、V조、HV조심기조망지수급심기caspase-3농도명현강저(P<0.05),심기HGF、항심기조망단백Bcl-xl수평명현승고(P<0.05),차연합용약조우위현저。결론 HGF、힐사탄균가유효억제SHR좌심실심기세포조망,개선심실중구,차연합사용효과우우HGF、힐사탄적단독응용。
Objective To observe the effect of HGF combined with valsartan on myocardial apoptosis in spontaneously hypertensive rats.Methods 24 -old male SHRs age,14 -week,were randomly divided into 4 groups:positive control group (P group,conventional breeding,with no drug intervention),HGF group (H group,the left ventricle walls were injected with 0.1ml 5x109Pfu/mL Ad5 -HGF at five different points after thoracotomy and then fed them normally for 4 weeks),valsartan group (V group,intragastric administration of valsartan 30 mgokg-1od-1 for 4 weeks),HGF plus valsartan group (HV group,the left ventricle walls were injected with 0.1ml 5x109Pfu/mL Ad5 -HGF,at five different points after thoracotomy and then valsartan at a dose f 30 mgokg-1od-1was intragastrically administrated for 4 weeks),and male Wistar rats (WKY)were used as normal controls (N group,n=6).The tail blood pressure was measured once a week before and after treatment.The rats were sacrificed at the 4th week.The myocardial apoptosis index was measured by TUNEL,and the concentration of myocardial HGF and caspase-3 was measured by ELASA,the level of myocardial Bcl-xl was analyzed by immunohistochemistry and im-age analysis system.Results After 4 weeks'treatment,blood pressure in HV group and V group significantly de-creased (P<0.05).Compared with P group,H group,V group and HV group showed significant decrease in myocar-dial apoptosis index and myocardial caspase-3 levels(P<0.05 ),while increase in myocardial HGF and anti myo-cardial apoptosis protein Bcl-xl levels (P<0.05 ).Compared with H group or V group,HV group showed better effect.(P<0.05).Conclusion The combination of HGF and valsartan have better effect on myocardial apoptosis of SHR ventricular than HGF or valsartan alone.